Impaired thrombolysis: a novel cardiovascular risk factor in end-stage renal disease (original) (raw)
IV thrombolysis and renal function
Y. Roos
Neurology, 2013
View PDFchevron_right
The Use of Aspirin to Reduce the Risk of Thrombotic Events in Patients With End-Stage Renal Disease: Protocol for a Randomized Controlled Trial
Evelin Balbino
JMIR Research Protocols, 2018
View PDFchevron_right
Predictors of Cardiovascular Death in ESRD
F. Mallamaci
Seminars in Nephrology, 2005
View PDFchevron_right
Renal Impairment Reduces the Efficacy of Thrombolytic Therapy in Acute Ischemic Stroke
Albert Power
Cerebrovascular Diseases, 2013
View PDFchevron_right
Enhanced anticoagulant activity of enoxaparin in patients with ESRD as measured by thrombin generation time
Donald Brophy
American Journal of Kidney Diseases, 2004
View PDFchevron_right
Renal function and outcome among stroke patients treated with IV thrombolysis
Stefan Engelter
Neurology, 2008
View PDFchevron_right
Severe Renal Impairment Is Associated With Symptomatic Intracerebral Hemorrhage After Thrombolysis for Ischemic Stroke
Andrea Rocco
Stroke, 2013
View PDFchevron_right
Michael Eldar, for the SPRINT Study Group, and the Israeli Thrombolytic Survey
Shmuel Gottlieb
View PDFchevron_right
Is it Time to Reassess the SITS-MOST Criteria for Thrombolysis?
Estevo Santamarina
Stroke, 2009
View PDFchevron_right
Traditional and nontraditional risk factors as predictors of cerebrovascular events in patients with end stage renal disease
F. Rapisarda, Lorenzo Malatino
Journal of Hypertension, 2010
View PDFchevron_right
Renal Dysfunction and In‐Hospital Outcomes in Patients With Acute Ischemic Stroke After Intravenous Thrombolytic Therapy
Zhenzhen Rao
Journal of the American Heart Association, 2019
View PDFchevron_right
Incidence and Prevalence of Atrial Fibrillation (AF) in End Stage Renal Disease (ESRD) Patients
Shradha Ahuja
SM journal of nephrology and therapeutics, 2017
View PDFchevron_right
Fibrinogen, mortality and incident cardiovascular complications in end-stage renal failure
S. Cutrupi
Journal of Internal Medicine, 2003
View PDFchevron_right
Is it Time to Reassess the SITS-MOST Criteria for Thrombolysis?: A Comparison of Patients With and Without SITS-MOST Exclusion Criteria
Olga Maisterra, Gemma Ortega
Stroke, 2009
View PDFchevron_right
A comparative study of platelet parameters in end stage renal disease patients undergoing haemodialysis and healthy individuals
Shashank Tiwari
International Journal of Advances in Medicine, 2016
View PDFchevron_right
A point-of-care global thrombosis test measuring occlusion time and endogenous lysis time may indicate thrombotic status
Kjell Sakariassen
Future Science OA, 2019
View PDFchevron_right
Mortality Differences by Dialysis Modality among Incident ESRD Patients with and without Coronary Artery Disease
Friedrich Port
Journal of the American Society of Nephrology, 2003
View PDFchevron_right
The influence of atrial fibrillation on the mortality of incident ESRD patients undergoing maintenance hemodialysis
Jaw-Wen Chen
PLOS ONE, 2020
View PDFchevron_right
Intravenous rt-PA in patients with ischaemic stroke and renal dysfunction
Wiktor Szczuchniak
Clinical Neurology and Neurosurgery, 2013
View PDFchevron_right
Association of Mild to Moderate Chronic Kidney Disease With Venous Thromboembolism: Pooled Analysis of Five Prospective General Population Cohorts
Jens Hammerstrøm
Circulation, 2012
View PDFchevron_right
Increased risk of arterial thromboembolism after a prior episode of venous thromboembolism: results from the Prevention of REnal and Vascular ENd stage Disease (PREVEND) Study
Bakhtawar Mahmoodi
British Journal of Haematology, 2012
View PDFchevron_right
Cardioprotection in the ESRD Population: How Do We Get There?
seven hills
Hemodialysis International, 2002
View PDFchevron_right
Controversies in Thrombolysis
Peter Sandercock
Current Neurology and Neuroscience Reports, 2017
View PDFchevron_right
Platelet thrombus formation in patients with end-stage renal disease before and after hemodialysis as measured by the total thrombus-formation analysis system
Zorica Dimitrijevic
International Urology and Nephrology
View PDFchevron_right
Prognostic value of cardiac markers in ESRD: Chronic Hemodialysis and New Cardiac Markers Evaluation (CHANCE) study
Philippe Tuppin
American Journal of Kidney Diseases, 2003
View PDFchevron_right
Thrombin-Anti-Thrombin Levels and Patency of Arterio-Venous Fistula in Patients Undergoing Haemodialysis Compared to Healthy Volunteers: A Prospective Analysis
Julie Brittenden
PLoS ONE, 2013
View PDFchevron_right
Prognostic value of combined use of biomarkers of inflammation, endothelial dysfunction, and myocardiopathy in patients with ESRD
F. Mallamaci
Kidney International, 2005
View PDFchevron_right
Dialysis Dose and Risk Factors for Death Among ESRD Patients Treated with Twice-Weekly Hemodialysis: A Prospective Cohort Study
Dhavee Sirivongs
Blood Purification, 2014
View PDFchevron_right